HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme

MLA

Einthavy Arunachalam, et al. “HOX and PBX Gene Dysregulation as a Therapeutic Target in Glioblastoma Multiforme.” BMC Cancer, vol. 22, no. 1, Apr. 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12885-022-09466-8.

APA

Einthavy Arunachalam, William Rogers, Guy R. Simpson, Carla Möller-Levet, Gemma Bolton, Mohammed Ismael, Christopher Smith, Karl Keegen, Izhar Bagwan, Tim Brend, Susan C. Short, Bangxing Hong, Yoshihiro Otani, Balveen Kaur, Nicola Annels, Richard Morgan, & Hardev Pandha. (2022). HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer, 22(1), 1–13. https://doi.org/10.1186/s12885-022-09466-8

Chicago

Einthavy Arunachalam, William Rogers, Guy R. Simpson, Carla Möller-Levet, Gemma Bolton, Mohammed Ismael, Christopher Smith, et al. 2022. “HOX and PBX Gene Dysregulation as a Therapeutic Target in Glioblastoma Multiforme.” BMC Cancer 22 (1): 1–13. doi:10.1186/s12885-022-09466-8.